Women with BRCA2 pathogenic variants had a corresponding risk of 55% (95% CI, 41%-70%) and 16.5% (95% CI, 7.5%-34%) for breast and ovarian cancers, respectively (19). The gene discussed is BRCA2; the disease is ovarian cancer.